ISHARES TR - ISHARES BIOTECH (IBB)

CUSIP: 464287556

Q3 2022 13F Holders as of 30 Sep 2022

Share change
-525,832
Put/Call ratio
266%
SEC-reported price per share
$116.96
Number of holders
818
Value change
-$61,899,980
Number of buys
280
Open additional details 1 more signal available
Number of sells
371

Security key

464287556

Report period

Q3 2022

Institutions

818

Top holders

10

Ownership snapshot

Top reported holders of IBB - ISHARES TR - ISHARES BIOTECH (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
818
Shares
39,025,913
Rows available
818
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
847
Q3 2022 holders
818
Holder diff
-29
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .